Amneal Pharmaceuticals's market cap is currently $2.41B. The company's EPS TTM is $-0.684; its P/E ratio is ―; Amneal Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.39B	$ 2.21B	$ 2.09B	$ 1.99B	$ 1.63B
Gross Profit	$ 820.57M	$ 784.71M	$ 768.97M	$ 628.39M	$ 353.00M
Operating Income	$ 204.37M	$ 206.46M	$ 209.24M	$ 91.16M	$ -137.42M
EBITDA	$ 399.76M	$ 150.43M	$ 450.00M	$ 381.05M	$ 155.20M
Net Income	$ -83.99M	$ -254.79M	$ 20.17M	$ 68.58M	$ -603.57M
Balance Sheet
Cash & Short-Term Investments	$ 91.54M	$ 25.98M	$ 247.79M	$ 341.38M	$ 151.20M
Total Assets	$ 3.47B	$ 3.80B	$ 3.94B	$ 4.01B	$ 3.67B
Total Debt	$ 2.75B	$ 2.85B	$ 2.88B	$ 2.94B	$ 2.77B
Net Debt	$ 2.66B	$ 2.82B	$ 2.63B	$ 2.60B	$ 2.61B
Total Liabilities	$ 3.45B	$ 3.59B	$ 3.57B	$ 3.66B	$ 3.32B
Stockholders' Equity	$ 19.78M	$ 183.98M	$ 366.97M	$ 344.93M	$ 346.79M
Cash Flow
Free Cash Flow	$ 276.39M	$ -25.50M	$ 189.18M	$ 312.81M	$ -95.73M
Operating Cash Flow	$ 345.58M	$ 65.10M	$ 241.82M	$ 379.00M	$ 1.71M
Investing Cash Flow	$ -69.19M	$ -174.31M	$ -194.18M	$ -317.55M	$ -19.58M
Financing Cash Flow	$ -212.57M	$ -106.62M	$ -138.12M	$ 131.81M	$ -45.83M

Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History

Income Statement >

Amneal Pharmaceuticals Debt to Assets

Balance Sheet >

Amneal Pharmaceuticals Cash Flow

Cash Flow >

Amneal Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing